Tuberculosis (TB) : Exam point of view in detail
Tuberculosis (TB) : Exam point of view in detail
1. Definition
Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis.
It mainly affects the lungs (Pulmonary TB) but can also affect other organs (Extrapulmonary TB).
T B is the world's second most common cause of death from infectious disease after HIV /AIDS
2. Causative Agent
Organism: Mycobacterium tuberculosis
Type: Acid-fast bacillus (AFB)
Characteristics
Rod-shaped bacterium
Slow growing
Resistant due to waxy cell wall
Can remain dormant in body
3. Risk Factors
Important factors increasing TB risk:
- HIV infection
- Diabetes mellitus
- Malnutrition
- Low body weight
- Silicosis
- End stage kidney disease
- Cancer and chemotherapy
- Leukemia
- Genetic susceptibility
- Immunosuppressive drugs
- Overcrowding
- Poor ventilation
4. Mode of Transmission
Tuberculosis spreads mainly through the airborne route.
When a person with active pulmonary TB coughs, sneezes, laughs, or talks, tiny droplets containing TB bacteria are released into the air. These droplets may remain suspended in the air for a long time.
Healthy individuals become infected when they inhale these contaminated droplets.
Sources of infection:
- Coughing
- Sneezing
- Talking
- Close contact with TB patient
When infected droplets are inhaled, bacteria enter the lungs.
5. Incubation Period
Usually 2–8 weeks.
Bacteria may remain latent for months or even years.
During this time, the bacteria multiply in the body but symptoms may not appear. In some individuals, the bacteria remain inactive (latent) for months or even years.
When immunity decreases, the bacteria can become active and cause disease.
6. Types of Tuberculosis
1. Pulmonary TB
Affects lungs
Most common form
Main source of transmission
2. Extrapulmonary TB
Affects organs other than lungs:
Examples:
Lymph nodes
Bones and joints
Brain (TB meningitis)
Kidneys
Intestines
7. Stages of TB Infection
1. Exposure
Person inhales TB bacteria.
2. Latent TB Infection
Bacteria remain inactive.
No symptoms.
Person not contagious.
3. Active TB Disease
Bacteria multiply.
Symptoms appear.
Person becomes infectious.
8. Signs and Symptoms
Common symptoms:
- Persistent cough (3 weeks)
- Fever
- Night sweats
- Weight loss
- Loss of appetite
- Fatigue
- Chest pain
- Shortness of breath
- Hemoptysis (blood in sputum)
9. Physical Examination
General Signs
- Fever
- Weight loss
- Weakness
- Night sweats
- Respiratory Signs
- Crackles (rales)
- Bronchial breathing
- Dullness on percussion
- Reduced breath sounds
10. Laboratory Diagnosis
1. Screening Tests
Mantoux Test (Tuberculin Skin Test)
Intradermal injection of tuberculin.
Positive reaction indicates TB exposure.
TB Blood Test (IGRA)
Measures immune response to TB bacteria.
# TB Skin Test (Mantoux/PPD): Tuberculin fluid is injected under the skin; a positive reaction (bump) indicates prior exposure.
# TB Blood Test (IGRA): Measures immune response (interferon-gamma release) in a blood sample when mixed with TB antigens; preferred for vaccinated
2. Diagnostic Tests
Sputum Smear Microscopy
Detects acid-fast bacilli (AFB).
NAAT / PCR
Detects TB DNA rapidly.
Mycobacterial Culture
Gold standard test.
Confirms TB infection.
Chest X-Ray
Shows lung lesions, cavities and infiltrates.
#Sputum Smear Microscopy: Stains sputum to detect acid-fast bacilli (AFB), a quick but less sensitive method.
# Nucleic Acid Amplification Tests (NAAT/PCR): Rapidly detects TB DNA in samples (sputum, gastric aspirate, etc.)
# Mycobacterial Culture: Grows M. tuberculosis from samples, confirming diagnosis but taking weeks.
# Chest X-ray (CXR): Looks for characteristic lung abnormalities in symptomatic patients.
Other Samples & Tests
# Induced Sputum/Bronchoscopy: For hard-to-produce samples, especially in children (gastric aspirate) or difficult cases.
# Molecular Drug Susceptibility Testing (DST): Detects genetic mutations for rapid drug resistance identification, crucial for treatment.
# Other Samples: Urine (genitourinary TB), Cerebrospinal Fluid (CSF) (meningitis)
11. Extrapulmonary TB Signs
- Lymph Node TB
- Enlarged cervical lymph nodes
- Bone TB (Pott's disease)
- Spine infection
- Back pain
- Spinal deformity
- Abdominal TB
- Abdominal pain
- Ascites
- Abdominal swelling
12. Prevention
1. BCG Vaccination
Bacillus Calmette–Guérin vaccine
Given at birth
Protects children from severe TB
2. Public Health Measures
Early detection
Isolation of active TB patients
Use of masks
Good ventilation
Avoid overcrowding
13. Treatment
Treatment requires long-term combination therapy.
First Line Anti-TB Drugs
- Isoniazid
- Rifampicin
- Ethambutol
- Pyrazinamide
Usually 6 months.
14. Drug Resistant TB
Types:
MDR-TB
Resistant to Isoniazid and Rifampicin
XDR-TB
Resistant to multiple second-line drugs
Treatment requires specialized therapy.
15. Supportive Management
- Proper nutrition
- Adequate rest
- Regular follow-up
- Monitoring drug side effects
16. Complications
If untreated, TB may cause:
- Lung damage
- Respiratory failure
- TB meningitis
- Bone deformity
- Spread to other organs
* Short Summary *
Disease: Tuberculosis
Causative Agent: Mycobacterium tuberculosis
Transmission: Airborne droplets
Common Symptoms: Cough, fever, night sweats, weight loss
Diagnosis: Mantoux test, sputum smear, PCR, culture, chest X-ray
Treatment: Combination anti-TB drugs for 6 months
Prevention: BCG vaccination and infection control
Summary
Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis. It mainly affects the lungs (pulmonary TB) but can also involve other organs such as lymph nodes, bones, brain, and kidneys (extrapulmonary TB). The disease spreads through airborne droplets when an infected person coughs, sneezes, or talks. Common symptoms include persistent cough, fever, night sweats, weight loss, fatigue, and sometimes coughing up blood. Diagnosis is done through tests such as the Mantoux test, sputum smear microscopy, PCR/NAAT, mycobacterial culture, and chest X-ray. Treatment requires a combination of anti-tuberculosis drugs like isoniazid, rifampicin, ethambutol, and pyrazinamide for about six months. Prevention includes BCG vaccination, early diagnosis, proper ventilation, avoiding overcrowding, and effective infection control measures to reduce the spread of the disease.
.
.
.
.
.
.

Comments
Post a Comment